Skills Development Author Response to Academic Reviews

Author Response to Academic Reviews

v20260724
icse-author-response
A comprehensive guide for structuring author responses to major academic conference reviews (e.g., ICSE). It distinguishes between the initial 'author response' and the structured 'Major Revision' letter. Learn how to address specific review criteria (Novelty, Rigor, Relevance, Verifiability) using a technical, neutral 'ledger' format, ensuring every claim is evidence-based and professionally presented.
Get Skill
275 downloads
Overview

ICSE Author Response

ICSE gives authors two distinct speaking turns, and they demand different documents. The author response (September in the 2027 cycle, checked 2026-07-08) answers reviews before first decisions; the Major Revision response letter (revision due November 17, 2026; final decision December 18) accompanies a changed paper re-read by the same reviewers. Do not write the first as if it were the second.

Turn 1: the author response

You are writing for the PC discussion, not for your own catharsis. Three moves earn their space:

  1. Correct factual misreadings, with a page/section pointer: "R2 states we evaluate on toy programs; §5.1 lists the 17 real-world projects (median 210 kLOC)."
  2. Supply requested evidence that already exists — a number, a table cell, a clarification of the study protocol. If it fits in a sentence, give the sentence, not a promise.
  3. Commit to feasible changes, scoped to what a Major Revision window can hold. "We will add effect sizes to Table 4" is credible; "we will run a controlled experiment with professional developers" is not.

Map every reply to the criterion it defends. ICSE reviews are structured around novelty, rigor, relevance, and verifiability/transparency — a response that answers a rigor objection with a relevance argument reads as evasion.

Objection pattern Criterion under attack Response that works
"Delta over [X] unclear" Novelty One-paragraph contrast: what X cannot do, with citation and evidence pointer
"Only N subjects / projects" Rigor Justify N against comparable published studies; show per-subject variance
"Why would practitioners care?" Relevance Concrete failure cost, practitioner quote, or deployment context from the paper
"Cannot tell how the tool works" Verifiability Point to artifact + name the exact section/README that answers it
"Threats section is boilerplate" Rigor Name the one threat that genuinely worries you and the mitigation you ran

Response mechanics for the current cycle (length cap, structured forms, whether revised PDFs are allowed) were not published at check time — 待核实 on the HotCRP site when the window opens. Draft to fit the tightest historical norm: short, numbered, no new-contribution smuggling.

Turn 2: the Major Revision

A Major Revision at ICSE is an itemized contract. The meta-review or reviews enumerate required changes; December's decision largely reduces to whether each item is verifiably addressed. The four-week window (Oct 20 notification → Nov 17 revision in 2027) sets the feasibility bar for what you promise.

Structure the response letter as a ledger:

# Response to Reviews — Submission #NNN (Major Revision)

## Summary of changes
Three sentences: the big moves, in reviewer language.

## R1.1 (rigor) — "No baseline against static analysis tools."
**Change:** Added SpotBugs and Infer as baselines; new §5.3, Table 6.
**Where:** pp. 6–7, marked in blue.

## R1.2 (verifiability) — "Prompt templates not disclosed."
**Change:** Full templates now in the replication package (`prompts/`),
summarized in §4.2.

## R3.4 — "Compare on industrial code."
**Declined, with reason:** licensing prevents redistribution; we instead added
two large OSS systems (§5.1) and state the limit in Threats (§7).

Rules of the ledger: every numbered reviewer point appears, including the ones you decline; every change names its section and page; declined items get a reason, never silence. Submit a diff-marked PDF if the instructions allow one — reviewers granted four weeks of their own time deserve not to hunt.

Revision-sprint triage

With four weeks, order work by decision impact per day:

  1. Days 1–3: parse all reviews into the ledger; agree the decline list with coauthors; email the chairs only if a required change is genuinely ambiguous.
  2. Week 1–2: the evidence items — new baselines, added analyses, statistics. These have the longest compute/writing tails.
  3. Week 3: framing items — intro repositioning, related-work additions, threats rewrite.
  4. Final days: ledger completion pass, diff-PDF build, artifact update so the package matches the revised claims.

Tone calibration

The register that works is technical-neutral: no wounded pride, no flattery, no lawyering. Compare:

  • Defensive: "The reviewer apparently did not read §5, where this is clearly explained." → Working: "§5.2 (Table 4, row 3) reports this; we will make the forward reference in §3 explicit."
  • Over-conceding: "We agree our evaluation is limited and will try to improve." → Working: "We agree external validity is bounded by the Java focus; we now state this in §7 and add two non-JVM subjects to the package's extension guide."

Concede real weaknesses precisely (it buys credibility for the pushbacks); push back on real errors respectfully (silence reads as agreement).

Anti-patterns

  • The grateful essay. Paragraphs of thanks before content; reviewers read ledgers, not letters of appreciation.
  • The stealth rewrite. Changing sections nobody complained about invites fresh objections in December with no turn left to answer them.
  • The optimistic promise in Turn 1 that Turn 2 cannot keep — reviewers keep receipts across turns; an unkept response commitment is a rejection reason all by itself.
  • Artifact drift: revised claims with an unrevised replication package fails exactly the verifiability criterion the revision was meant to satisfy.

Output format

[Turn] author response / major revision
[Ledger] N reviewer points -> addressed / declined-with-reason / needs decision
[Feasibility] promised work vs days remaining to Nov 17
[Risk items] points where the December decision could still go against you
Info
Category Development
Name icse-author-response
Version v20260724
Size 6.11KB
Updated At 2026-07-28
Language